Syndax Pharmaceuticals (NASDAQ:SNDX) Given New $36.00 Price Target at HC Wainwright
Syndax Pharmaceuticals (NASDAQ:SNDX – Get Rating) had its target price raised by HC Wainwright from $33.00 to $36.00 in a research report released on Tuesday morning, The Fly reports. HC Wainwright also issued estimates for Syndax Pharmaceuticals’ Q2 2023 earnings at ($0.70) EPS, Q3 2023 earnings at ($0.83) EPS, Q3 2023 earnings at ($0.83) EPS, […]